Pharmacogenomics Technology and Theranostics and Companion Diagnostics Market

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Comparison by Region (M USD)
Table 5. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) as of 2022)
Table 10. Global Market Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Sites and Area Served
Table 12. Manufacturers Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Type
Table 13. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Challenges
Table 22. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Type (K Units)
Table 23. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size by Type (M USD)
Table 24. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Type (2019-2024)
Table 26. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Share by Type (2019-2024)
Table 28. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) by Application
Table 30. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size by Application
Table 31. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Application (2019-2024)
Table 33. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Application (2019-2024)
Table 35. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Region (2019-2024)
Table 38. North America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales by Region (2019-2024) & (K Units)
Table 43. Qiagen NV Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 44. Qiagen NV Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 45. Qiagen NV Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Qiagen NV Business Overview
Table 47. Qiagen NV Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) SWOT Analysis
Table 48. Qiagen NV Recent Developments
Table 49. GE Healthcare Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 50. GE Healthcare Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 51. GE Healthcare Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) SWOT Analysis
Table 54. GE Healthcare Recent Developments
Table 55. Agilent Technologies Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 56. Agilent Technologies Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 57. Agilent Technologies Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) SWOT Analysis
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Recent Developments
Table 61. F Hoffman La Roche Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 62. F Hoffman La Roche Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 63. F Hoffman La Roche Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. F Hoffman La Roche Business Overview
Table 65. F Hoffman La Roche Recent Developments
Table 66. Foundation Medicine Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 67. Foundation Medicine Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 68. Foundation Medicine Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Foundation Medicine Business Overview
Table 70. Foundation Medicine Recent Developments
Table 71. Thermo Fisher Scientific Inc. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 72. Thermo Fisher Scientific Inc. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 73. Thermo Fisher Scientific Inc. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Thermo Fisher Scientific Inc. Business Overview
Table 75. Thermo Fisher Scientific Inc. Recent Developments
Table 76. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 77. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 78. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Leica Biosystems Nussloch GmBH Business Overview
Table 80. Leica Biosystems Nussloch GmBH Recent Developments
Table 81. Pfizer Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Basic Information
Table 82. Pfizer Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Product Overview
Table 83. Pfizer Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Region (2025-2030) & (K Units)
Table 87. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Country (2025-2030) & (K Units)
Table 89. North America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Country (2025-2030) & (K Units)
Table 91. Europe Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Region (2025-2030) & (K Units)
Table 93. Asia Pacific Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Country (2025-2030) & (K Units)
Table 95. South America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Type (2025-2030) & (K Units)
Table 99. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 101. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) Forecast by Application (2025-2030)
Table 102. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size (M USD), 2019-2030
Figure 5. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size (M USD) (2019-2030)
Figure 6. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size by Country (M USD)
Figure 11. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Share by Manufacturers in 2023
Figure 12. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Revenue Share by Manufacturers in 2023
Figure 13. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Type
Figure 18. Sales Market Share of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) by Type (2019-2024)
Figure 19. Sales Market Share of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) by Type in 2023
Figure 20. Market Size Share of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Application
Figure 24. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Application in 2023
Figure 26. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Application (2019-2024)
Figure 27. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share by Application in 2023
Figure 28. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Country in 2023
Figure 32. U.S. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Country in 2023
Figure 37. Germany Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Region in 2023
Figure 44. China Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (K Units)
Figure 50. South America Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Country in 2023
Figure 51. Brazil Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Share Forecast by Application (2025-2030)